CMS Suspends Part B CAP As Vendors Avoid Program; Overhaul May Follow
The competitive acquisition program for Medicare Part B drugs and biologics will be put on hold in 2009 because of a lack of interest among specialty drug distributors in becoming approved vendors
You may also be interested in...
Distributors, specialty pharmacies and PBMs are in a better position now to act as vendors then they were a decade ago, when Medicare unsuccessfully tried to implement a Medicare Part B prescription drug competitive acquisition program, HHS Secretary Azar points out.
Medicare pilot program on value-based purchasing could be challenged by a lack of therapeutic consensus as much as by opposition towards reduced reimbursement.
Figuring out how the Medicare Part B competitive acquisition program can be made more attractive for specialty drug distributors within the confines of the statute could be a tall order for CMS